Tomoko Arakaki

1.3k total citations
27 papers, 760 citations indexed

About

Tomoko Arakaki is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tomoko Arakaki has authored 27 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 6 papers in Psychiatry and Mental health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tomoko Arakaki's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Tomoko Arakaki is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Tomoko Arakaki collaborates with scholars based in Argentina, Spain and Cuba. Tomoko Arakaki's co-authors include Nélida Garretto, Mayela Rodríguez‐Violante, Juan Carlos Martínez‐Castrillo, Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, Mario Álvarez, José Manuel Rojo-Abuín, К. Ray Chaudhuri, Marcos Serrano‐Dueñas and Glenn T. Stebbins and has published in prestigious journals such as Neurology, Movement Disorders and Journal of Neurology.

In The Last Decade

Tomoko Arakaki

25 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Arakaki Argentina 13 583 167 113 109 83 27 760
Nélida Garretto Argentina 13 495 0.8× 153 0.9× 97 0.9× 94 0.9× 65 0.8× 28 662
Jocelyn Gomez Spain 6 570 1.0× 223 1.3× 145 1.3× 127 1.2× 59 0.7× 6 804
Lorenzo Morlán Gracia Spain 4 535 0.9× 200 1.2× 113 1.0× 114 1.0× 52 0.6× 6 683
Mario Álvarez Cuba 12 706 1.2× 190 1.1× 101 0.9× 215 2.0× 59 0.7× 23 974
S Wells United Kingdom 4 520 0.9× 264 1.6× 103 0.9× 218 2.0× 49 0.6× 5 760
Ulrike Suenkel Germany 12 285 0.5× 143 0.9× 102 0.9× 135 1.2× 33 0.4× 26 620
Martijn Broen Netherlands 11 649 1.1× 91 0.5× 40 0.4× 116 1.1× 132 1.6× 17 825
Amin Cervantes‐Arriaga Mexico 18 646 1.1× 105 0.6× 30 0.3× 159 1.5× 172 2.1× 112 880
Meredith Spindler United States 15 488 0.8× 161 1.0× 37 0.3× 106 1.0× 43 0.5× 38 772
Prachaya Srivanitchapoom Thailand 12 463 0.8× 95 0.6× 32 0.3× 138 1.3× 157 1.9× 41 727

Countries citing papers authored by Tomoko Arakaki

Since Specialization
Citations

This map shows the geographic impact of Tomoko Arakaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Arakaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Arakaki more than expected).

Fields of papers citing papers by Tomoko Arakaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Arakaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Arakaki. The network helps show where Tomoko Arakaki may publish in the future.

Co-authorship network of co-authors of Tomoko Arakaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Arakaki. A scholar is included among the top collaborators of Tomoko Arakaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Arakaki. Tomoko Arakaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Garretto, Nélida, et al.. (2021). A high dose tango intervention for people with Parkinson's disease (PwPD). Advances in Integrative Medicine. 8(4). 272–277. 2 indexed citations
4.
Martínez‐Martín, Pablo, José Manuel Rojo-Abuín, Mayela Rodríguez‐Violante, et al.. (2016). Analysis of four scales for global severity evaluation in Parkinson’s disease. npj Parkinson s Disease. 2(1). 16007–16007. 20 indexed citations
5.
Rodríguez‐Blázquez, Carmen, Mario Álvarez, Tomoko Arakaki, et al.. (2016). Self‐Assessment of Disability in Parkinson's Disease: The MDSUPDRS Part II Versus Clinician‐Based Ratings. Movement Disorders Clinical Practice. 4(4). 529–535. 13 indexed citations
6.
Ambrosio, Leire, Mari Carmen Portillo, Carmen Rodríguez‐Blázquez, et al.. (2016). Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population. Parkinsonism & Related Disorders. 25. 52–57. 18 indexed citations
7.
Ambrosio, Leire, Mari Carmen Portillo, Carmen Rodríguez‐Blázquez, et al.. (2016). Living with chronic illness scale: international validation of a new self-report measure in Parkinson’s disease. npj Parkinson s Disease. 2(1). 16022–16022. 14 indexed citations
8.
Arakaki, Tomoko, et al.. (2014). Commentary on neuromyelitis optica associated with painful paroxysmal dystonia: case report and literature review. Acta Neurologica Belgica. 115(3). 523–524. 3 indexed citations
9.
Martínez‐Martín, Pablo, Carmen Rodríguez‐Blázquez, Mario Álvarez, et al.. (2014). Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale. Parkinsonism & Related Disorders. 21(1). 50–54. 236 indexed citations
10.
Martínez‐Martín, Pablo, Carmen Rodríguez‐Blázquez, Maria João Forjaz, et al.. (2014). Relationship between the MDS‐UPDRS domains and the health‐related quality of life of Parkinson's disease patients. European Journal of Neurology. 21(3). 519–524. 40 indexed citations
11.
Rey, Roberto, et al.. (2014). Dramatic Improvement of Parkinsonism While Dancing Tango. Movement Disorders Clinical Practice. 1(4). 388–389. 1 indexed citations
12.
Arakaki, Tomoko, et al.. (2014). Hemimasticatory Spasm: Report of a Case and Review of the Literature. Tremor and Other Hyperkinetic Movements. 4(0). 210–210. 12 indexed citations
13.
Melamud, Luciana, et al.. (2013). Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica. Arquivos de Neuro-Psiquiatria. 71(5). 280–283. 10 indexed citations
14.
Rodríguez‐Blázquez, Carmen, José Manuel Rojo-Abuín, Mario Álvarez, et al.. (2013). The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism & Related Disorders. 19(10). 889–893. 62 indexed citations
15.
González‐Morón, Dolores, et al.. (2013). [The broad phenotypic spectrum of SCA-3: hereditary spastic paraplegia].. PubMed. 73(6). 552–4. 4 indexed citations
16.
Martínez‐Martín, Pablo, К. Ray Chaudhuri, José Manuel Rojo-Abuín, et al.. (2013). Assessing the non‐motor symptoms of Parkinson's disease: MDSUPDRS and NMS Scale. European Journal of Neurology. 22(1). 37–43. 74 indexed citations
17.
Martínez‐Martín, Pablo, Carmen Rodríguez‐Blázquez, Mario Álvarez, et al.. (2012). Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Journal of Neurology. 260(1). 228–236. 174 indexed citations
18.
Arakaki, Tomoko, et al.. (2006). Estudio comparativo de las funciones ejecutivas entre pacientes con enfermedad de Parkinson y pacientes con enfermedad degenerativa cerebelosa. Arquivos de Neuro-Psiquiatria. 64(3b). 814–823. 2 indexed citations
19.
Arakaki, Tomoko, et al.. (2005). Evaluación cognitiva en 12 pacientes con enfermedad cerebelosa degenerativa pura. Revista de Neurología. 40(8). 465–465. 8 indexed citations
20.
Garretto, Nélida, et al.. (2004). Improvement of blepharospasm with Zolpidem. Movement Disorders. 19(8). 967–968. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026